Pyschiatric Advance Directives Effective for Mental Disorders
MONDAY, Aug. 22, 2022 (HealthDay News) -- Peer worker-facilitated psychiatric advance directives (PW-PAD) are effective for decreasing compulsory hospital admissions among people with mental disorders, according to a study recently published in JAMA Psychiatry.
Aurélie Tinland, M.D., Ph.D., from Aix-Marseille University in France, and colleagues determined the efficacy of PW-PAD in mental disorders in a multicenter randomized clinical trial. Adults with a diagnosis of schizophrenia, bipolar I disorder, or schizoaffective disorder who had a compulsory admission in the past 12 months were enrolled. The primary outcome was the rate of compulsory admission 12 months after randomization in 394 participants (196 assigned to the PW-PAD group and 198 to the control group).
The researchers found that 27.0 and 39.9 percent of participants in the PW-PAD and control groups, respectively, had compulsory admissions. There were no significant differences observed between the groups in the rate of overall admission, therapeutic alliance score, or quality of life. Fewer symptoms, greater empowerment, and a higher recovery score were seen for participants in the PW-PAD group versus the control group (effect sizes, 0.20, 0.30, and 0.44, respectively).
"These findings support the use of PW-PADs for people with schizophrenia, bipolar I disorder, or schizoaffective disorder," the authors write. "Legal and organizational initiatives that promote supported decision making can develop the activity of peer workers to fulfill this mission."
Related Posts
U.S. Prison Inmates Aren’t Getting Medical Care They Need: Report
FRIDAY, April 14, 2023 (HealthDay News) -- U.S. prison inmates may be severely...
¿Dormir 6 horas es suficiente?
VIERNES, 10 de marzo de 2023 (HealthDay News) -- Cuando el trabajo, la crianza...
Black Children With Asthma More Likely to Receive Bronchodilators From EMS
WEDNESDAY, Oct. 11, 2023 (HealthDay News) -- Black children receiving emergency...
Implanted ‘Drug Factory’ Wipes Out Cancers in Mice — Could It Help People?
THURSDAY, March 3, 2022 (HealthDay News) -- Tiny, implantable drug "factories"...